Joseph F. Antognini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joseph F. Antognini has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Earl Carstens
‡Section of Neurobiology, Physiology and Behavior, University of California, Davis, California
15 shared publicationsE. Carstens
Department of Anesthesiology and Pain Medicineand2Section of Neurobiology, Physiology and Behavior, University of California, Davis, CA, USA
12 shared publicationsRichard J. Atherley
6 shared publicationsRichard Atherley
Department of Anesthesiology and Pain Medicine, University of California, Davis, California
5 shared publicationsSteven L. Jinks
5 shared publicationsXiao Wei Wang
Department of Anesthesiology, Kunming Medical College, Kunming, China
5 shared publications
Latest Publications
- 27 October 2026
- Published by Wolters Kluwer Health in Anesthesiology
Nociception during General Anesthesia: Comment
Was not provided for this article.
- 27 October 2026
- Published by Wolters Kluwer Health in Anesthesiology
Nociception during General Anesthesia: Comment
Was not provided for this article.
- 3 February 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 143 (2) , 431-433
A New General Anesthetic BTTE: Physical Properties, Hypnotic and Hemodynamic Effects in Rats, and Effects on GABA and NMDA Receptors Expressed in Frog Oocytes
- 3 February 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 143 (2) , 431-433
A New General Anesthetic BTTE: Physical Properties, Hypnotic and Hemodynamic Effects in Rats, and Effects on GABA and NMDA Receptors Expressed in Frog Oocytes
- Open Access
- 1 June 2015
- Published by Springer Nature in BMC Health Services Research
- Vol. 15 (1) , 1-9
How many operating rooms are needed to manage non-elective surgical cases? A Monte Carlo simulation study
Patients often wait to have urgent or emergency surgery. The number of operating rooms (ORs) needed to minimize waiting time while optimizing resources can be determined using queuing theory and computer simulation. We developed a computer program using Monte Carlo simulation to determine the number of ORs needed to minimize patient wait times while optimizing resources. We used patient arrival data and surgical procedure length from our institution, a tertiary-care academic medical center that serves a large diverse population. With ~4800 patients/year requiring non-elective surgery, and mean procedure length 185 min (median 150 min) we determined the number of ORs needed during the day and evening (0600–2200) and during the night (2200–0600) that resulted in acceptable wait times. Simulation of 4 ORs at day/evening and 3 ORs at night resulted in median wait time = 0 min (mean = 19 min) for emergency cases requiring surgery within 2 h, with wait time at the 95th percentile = 109 min. Median wait time for urgent cases needing surgery within 8–12 h was 34 min (mean = 136 min), with wait time at the 95th percentile = 474 min. The effect of changes in surgical length and volume on wait times was determined with sensitivity analysis. Monte Carlo simulation can guide decisions on how to balance resources for elective and non-elective surgical procedures.
- 1 June 2015
- Published by Springer Nature in BMC Health Services Research
- Vol. 15 (1) , 1-9
Open AccessHow many operating rooms are needed to manage non-elective surgical cases? A Monte Carlo simulation study
Patients often wait to have urgent or emergency surgery. The number of operating rooms (ORs) needed to minimize waiting time while optimizing resources can be determined using queuing theory and computer simulation. We developed a computer program using Monte Carlo simulation to determine the number of ORs needed to minimize patient wait times while optimizing resources. We used patient arrival data and surgical procedure length from our institution, a tertiary-care academic medical center that serves a large diverse population. With ~4800 patients/year requiring non-elective surgery, and mean procedure length 185 min (median 150 min) we determined the number of ORs needed during the day and evening (0600–2200) and during the night (2200–0600) that resulted in acceptable wait times. Simulation of 4 ORs at day/evening and 3 ORs at night resulted in median wait time = 0 min (mean = 19 min) for emergency cases requiring surgery within 2 h, with wait time at the 95th percentile = 109 min. Median wait time for urgent cases needing surgery within 8–12 h was 34 min (mean = 136 min), with wait time at the 95th percentile = 474 min. The effect of changes in surgical length and volume on wait times was determined with sensitivity analysis. Monte Carlo simulation can guide decisions on how to balance resources for elective and non-elective surgical procedures.
- 1 December 2011
- Published by Oxford University Press (OUP)
- p. 107-119
Anesthetic-Induced Immobility
- Open Access
- 1 September 2010
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 113 (3) , 758-759
All Valve Malfunctions Are Not the Same
- 1 September 2010
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 113 (3) , 758-759
Open AccessAll Valve Malfunctions Are Not the Same
- 1 February 2010
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 110 (2) , 638
Organotypic Cultures of Spinal Cord Ventral Horn Are Valuable Tools for Investigating Immobility-Related Mechanisms In Vitro
- 1 February 2010
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 110 (2) , 638
Organotypic Cultures of Spinal Cord Ventral Horn Are Valuable Tools for Investigating Immobility-Related Mechanisms In Vitro
- 1 May 2009
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 108 (5) , 1531-1537
Propofol Produces Immobility via Action in the Ventral Horn of the Spinal Cord by a GABAergic Mechanism
L (1 effective dose, ED50) or isoflurane (1 minimum alveolar concentration) anesthesia. During recording of ventral horn neurons, we administered picrotoxin by infusion to determine whether isoflurane and propofol differed in their effects at the γ aminobutyric acid (GABA) Type A receptors. We also determined whether decerebration altered propofol requirements to produce immobility. RESULTS: Decerebration did not affect propofol requirements. The ED50 for propofol was 497 ± 58 μg · kg−1 · min−1 in intact rats and 420 ± 65 μg · kg−1 · min−1 in decerebrated rats (P > 0.05), with corresponding propofol blood concentrations of 8.1 ± 1.1 μg/mL and 7.3 ± 1.1 μg/mL, respectively (P > 0.05). Propofol did not significantly depress dorsal horn neurons, but isoflurane depressed the responses to 56% of control (P < 0.05). Propofol depressed ventral horn neurons to 47% of control, whereas isoflurane depressed ventral horn neurons to 20% of control. Picrotoxin significantly reversed the depressant effect of propofol on ventral horn neuronal responses (79% of control, not significantly different from control). Pic- rotoxin, however, had no effect on isoflurane's depression of ventral horn neuronal responses (26% of control). CONCLUSIONS: Propofol acts in the spinal cord to produce immobility. This depressive effect occurs in the ventral horn and is mediated mainly by GABAA receptors. Isoflurane also depresses neurons in the ventral horn; however, isoflurane actions at the GABAA receptor are either weak or overridden by other effects in the ventral horn....
- 1 May 2009
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 108 (5) , 1531-1537
Propofol Produces Immobility via Action in the Ventral Horn of the Spinal Cord by a GABAergic Mechanism
L (1 effective dose, ED50) or isoflurane (1 minimum alveolar concentration) anesthesia. During recording of ventral horn neurons, we administered picrotoxin by infusion to determine whether isoflurane and propofol differed in their effects at the γ aminobutyric acid (GABA) Type A receptors. We also determined whether decerebration altered propofol requirements to produce immobility. RESULTS: Decerebration did not affect propofol requirements. The ED50 for propofol was 497 ± 58 μg · kg−1 · min−1 in intact rats and 420 ± 65 μg · kg−1 · min−1 in decerebrated rats (P > 0.05), with corresponding propofol blood concentrations of 8.1 ± 1.1 μg/mL and 7.3 ± 1.1 μg/mL, respectively (P > 0.05). Propofol did not significantly depress dorsal horn neurons, but isoflurane depressed the responses to 56% of control (P < 0.05). Propofol depressed ventral horn neurons to 47% of control, whereas isoflurane depressed ventral horn neurons to 20% of control. Picrotoxin significantly reversed the depressant effect of propofol on ventral horn neuronal responses (79% of control, not significantly different from control). Pic- rotoxin, however, had no effect on isoflurane's depression of ventral horn neuronal responses (26% of control). CONCLUSIONS: Propofol acts in the spinal cord to produce immobility. This depressive effect occurs in the ventral horn and is mediated mainly by GABAA receptors. Isoflurane also depresses neurons in the ventral horn; however, isoflurane actions at the GABAA receptor are either weak or overridden by other effects in the ventral horn....
- 1 January 2009
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 108 (1) , 160-167
Modeling the Gabaergic Action of Etomidate on the Thalamocortical System
BACKGROUND: We have used a computational model of the thalamocortical system to investigate the effects of a GABAergic anesthetic (etomidate) on cerebral cortical and thalamic neuronal function. We examined the effects of phasic and tonic inhibition, as well as the relative importance of anesthetic action in the thalamus and cortex. METHODS: The amount of phasic GABAergic inhibition was adjusted in the model to simulate etomidate concentrations of between 0.25 and 2 μM, with the concentration range producing unconsciousness assumed to be between 0.25 and 0.5 μM. In addition, we modeled tonic inhibition separately, and then phasic and tonic inhibition together. We also introduced phasic and tonic inhibition into the cerebral cortex and thalamus separately to determine the relative importance of each of these structures to anesthetic-induced depression of the thalamocortical system. RESULTS: Phasic inhibition decreased cortical neuronal firing by 11%–18% in the 0.25–0.5 μM range and by 38% at 2 μM. Tonic inhibition produced similar depression (11%–21%) in the 0.25–0.5 μM range but 65% depression at 2 μM; phasic and tonic inhibition combined produced the most inhibition (76% depression at 2 μM). When the thalamus and cortex were separately subjected to phasic and tonic inhibition, cortical firing rates decreased less compared to when both structures were targeted. In the 0.25–0.5 μM range, cortical firing rate was minimally affected when etomidate action was simulated in the thalamus only. CONCLUSIONS: This computational model of the thalamocortical system indicated that tonic GABAergic inhibition seems to be more important than phasic GABAergic inhibition (especially at larger etomidate concentrations), although both combined had the most effect on cerebral cortical firing rates. Furthermore, etomidate action in the thalamus, by itself, does not likely explain etomidate-induced unconsciousness.
- 1 January 2009
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 108 (1) , 160-167
Modeling the Gabaergic Action of Etomidate on the Thalamocortical System
BACKGROUND: We have used a computational model of the thalamocortical system to investigate the effects of a GABAergic anesthetic (etomidate) on cerebral cortical and thalamic neuronal function. We examined the effects of phasic and tonic inhibition, as well as the relative importance of anesthetic action in the thalamus and cortex. METHODS: The amount of phasic GABAergic inhibition was adjusted in the model to simulate etomidate concentrations of between 0.25 and 2 μM, with the concentration range producing unconsciousness assumed to be between 0.25 and 0.5 μM. In addition, we modeled tonic inhibition separately, and then phasic and tonic inhibition together. We also introduced phasic and tonic inhibition into the cerebral cortex and thalamus separately to determine the relative importance of each of these structures to anesthetic-induced depression of the thalamocortical system. RESULTS: Phasic inhibition decreased cortical neuronal firing by 11%–18% in the 0.25–0.5 μM range and by 38% at 2 μM. Tonic inhibition produced similar depression (11%–21%) in the 0.25–0.5 μM range but 65% depression at 2 μM; phasic and tonic inhibition combined produced the most inhibition (76% depression at 2 μM). When the thalamus and cortex were separately subjected to phasic and tonic inhibition, cortical firing rates decreased less compared to when both structures were targeted. In the 0.25–0.5 μM range, cortical firing rate was minimally affected when etomidate action was simulated in the thalamus only. CONCLUSIONS: This computational model of the thalamocortical system indicated that tonic GABAergic inhibition seems to be more important than phasic GABAergic inhibition (especially at larger etomidate concentrations), although both combined had the most effect on cerebral cortical firing rates. Furthermore, etomidate action in the thalamus, by itself, does not likely explain etomidate-induced unconsciousness.
- 1 June 2008
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 106 (6) , 1759-1764
The Effects of Aromatic Anesthetics on Dorsal Horn Neuronal Responses to Noxious Stimulation
BACKGROUND: Gamma-aminobutyric acid type A receptor potentiation and/or N-methyl-d-aspartate (NMDA) receptor inhibition might explain the anesthetic properties of fluorinated aromatic compounds. We hypothesized that depression of dorsal horn neuronal responses to noxious stimulation would correlate with the magnitude of effect of benzene (BNZ), o-difluorobenzene, and hexafluorobenzene (HFB) on NMDA receptors. METHODS: Rats were anesthetized with desflurane. A T13-L1 laminectomy allowed extracellular recording of neuronal activity from the lumbar spinal cord. After discontinuing desflurane administration, MAC for each aromatic anesthetic was determined. A 5-s noxious mechanical stimulus was then applied to the hindpaw receptive field of nociceptive dorsal horn neurons, and single-neuron responses were recorded at 0.8 and 1.2 MAC. These responses were also recorded in decerebrate rats receiving BNZ and HFB at 0–1.2 MAC. RESULTS: In intact rats, depression of responses of dorsal horn neurons to noxious stimulation by peri-MAC increases in BZN, o-difluorobenzene, and HFB correlated directly with their in vitro capacity to block NMDA receptors. In decerebrate rats, 1.2 MAC BNZ depressed nociceptive responses by 60%, with a further percentage decrease continuing from 0.8 to 1.2 MAC approximately equal to that found in intact rats. In decerebrate rats, HFB caused a progressive dose-related decrease in MAC (maximum 25%), but in intact rats, an increase from 0.8 to 1.2 neuronal response caused an (insignificant) increase in neuronal response. CONCLUSIONS: The findings in intact rats suggest that NMDA blockade contributes to the depression of dorsal horn neurons to nociceptive stimulation by fluorinated aromatic anesthetics. These results, combined with the additional findings in decerebrate rats, suggest that supraspinal effects (perhaps on γ-aminobutyric acid type A receptors) may have a supraspinal facilitatory effect on nociception for HFB.
- 1 June 2008
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 106 (6) , 1759-1764
The Effects of Aromatic Anesthetics on Dorsal Horn Neuronal Responses to Noxious Stimulation
BACKGROUND: Gamma-aminobutyric acid type A receptor potentiation and/or N-methyl-d-aspartate (NMDA) receptor inhibition might explain the anesthetic properties of fluorinated aromatic compounds. We hypothesized that depression of dorsal horn neuronal responses to noxious stimulation would correlate with the magnitude of effect of benzene (BNZ), o-difluorobenzene, and hexafluorobenzene (HFB) on NMDA receptors. METHODS: Rats were anesthetized with desflurane. A T13-L1 laminectomy allowed extracellular recording of neuronal activity from the lumbar spinal cord. After discontinuing desflurane administration, MAC for each aromatic anesthetic was determined. A 5-s noxious mechanical stimulus was then applied to the hindpaw receptive field of nociceptive dorsal horn neurons, and single-neuron responses were recorded at 0.8 and 1.2 MAC. These responses were also recorded in decerebrate rats receiving BNZ and HFB at 0–1.2 MAC. RESULTS: In intact rats, depression of responses of dorsal horn neurons to noxious stimulation by peri-MAC increases in BZN, o-difluorobenzene, and HFB correlated directly with their in vitro capacity to block NMDA receptors. In decerebrate rats, 1.2 MAC BNZ depressed nociceptive responses by 60%, with a further percentage decrease continuing from 0.8 to 1.2 MAC approximately equal to that found in intact rats. In decerebrate rats, HFB caused a progressive dose-related decrease in MAC (maximum 25%), but in intact rats, an increase from 0.8 to 1.2 neuronal response caused an (insignificant) increase in neuronal response. CONCLUSIONS: The findings in intact rats suggest that NMDA blockade contributes to the depression of dorsal horn neurons to nociceptive stimulation by fluorinated aromatic anesthetics. These results, combined with the additional findings in decerebrate rats, suggest that supraspinal effects (perhaps on γ-aminobutyric acid type A receptors) may have a supraspinal facilitatory effect on nociception for HFB.
- 1 October 2007
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 105 (4) , 1020-1026
Neurons in the Ventral Spinal Cord Are More Depressed by Isoflurane, Halothane, and Propofol Than Are Neurons in the Dorsal Spinal Cord
Ral site within the spinal cord such as in premotor interneurons and motoneurons. We hypothesized that isoflurane, halothane, and propofol would exert a greater depressant effect on nociceptive responses of ventral horn neurons when compared with dorsal horn neurons. METHODS: Rats were anesthetized with isoflurane or halothane and responses of dorsal (1200 μm) lumbar neurons to noxious mechanical stimulation of the hindpaw were determined at 0.8 and 1.2 MAC. In a third group anesthetized with isoflurane at 0.8 MAC, we administered 5 mg/kg propofol while recording responses from dorsal horn or ventral horn neurons. RESULTS: Dorsal horn neuronal responses were not significantly affected when either isoflurane or halothane was increased from 0.8 to 1.2 MAC; propofol also had no significant effect. On the other hand, with increased isoflurane or halothane concentration, responses of ventral horn neurons were depressed by 60% and 45%, respectively. Propofol profoundly depressed (>90%) ventral horn neurons. CONCLUSIONS: These data suggest that, in the peri-MAC range, isoflurane, halothane, and propofol have little or no effect on neuronal responses to noxious mechanical stimulation in the spinal dorsal horn but depress such responses in the ventral horn. Immobility produced in the 0.8–1.2 MAC range by these anesthetics appears to result from a depressant action in the ventral horn....
- 1 October 2007
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 105 (4) , 1020-1026
Neurons in the Ventral Spinal Cord Are More Depressed by Isoflurane, Halothane, and Propofol Than Are Neurons in the Dorsal Spinal Cord
Ral site within the spinal cord such as in premotor interneurons and motoneurons. We hypothesized that isoflurane, halothane, and propofol would exert a greater depressant effect on nociceptive responses of ventral horn neurons when compared with dorsal horn neurons. METHODS: Rats were anesthetized with isoflurane or halothane and responses of dorsal (1200 μm) lumbar neurons to noxious mechanical stimulation of the hindpaw were determined at 0.8 and 1.2 MAC. In a third group anesthetized with isoflurane at 0.8 MAC, we administered 5 mg/kg propofol while recording responses from dorsal horn or ventral horn neurons. RESULTS: Dorsal horn neuronal responses were not significantly affected when either isoflurane or halothane was increased from 0.8 to 1.2 MAC; propofol also had no significant effect. On the other hand, with increased isoflurane or halothane concentration, responses of ventral horn neurons were depressed by 60% and 45%, respectively. Propofol profoundly depressed (>90%) ventral horn neurons. CONCLUSIONS: These data suggest that, in the peri-MAC range, isoflurane, halothane, and propofol have little or no effect on neuronal responses to noxious mechanical stimulation in the spinal dorsal horn but depress such responses in the ventral horn. Immobility produced in the 0.8–1.2 MAC range by these anesthetics appears to result from a depressant action in the ventral horn....